Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]

Affiliations

• ¹ University of California San Francisco Weill Institute for Neurosciences, Benioff Children's Hospital, San Francisco, CA, USA.
• ² Stichting Epilepsie Instellingen Nederland, Zwolle, the Netherlands.
• ³ Duke University School of Medicine, Durham, NC, USA.
• ⁴ Meyer Children's Hospital, Florence, Italy.
• ⁵ Adelaide Medical School & Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
• ⁶ University of New South Wales, Sydney, NSW, Australia.
• ⁷ Marinus Pharmaceuticals, Inc., Radnor, PA, USA.
• ⁸ Marinus Pharmaceuticals, Inc., Radnor, PA, USA. Electronic address: aaimetti@marinuspharma.com.
• ⁹ University of Arkansas for Medical Sciences, Little Rock, AK, USA.